IDEXX LABORATORIES INC /DE
Company Stats
- Market Cap
- $41.1B
- as of Sep 30, 2026
- Shares Outstanding
- 78.8M
- Free Float
- 99.2%
Income Statement
- Revenue
- $4.3B
- Operating Income
- $1.4B
- Net Income
- $1.1B
- EBITDA
- $1.5B
- Revenue Growth, 3Y
- 8.5%
- FCF Margin, 3Y Avg
- 22.1%
- FCF Margin, Worst Year
- 20.7%
Cash Flow
- Free Cash Flow
- $1.1B
- FCF Yield
- 2.6%
- Owner FCF Yield
- 2.4%
Balance Sheet
- Cash & Equivalents
- $180.1M
Returns & Capital
- Share Repurchases
- $1.2B
- Buyback Yield, 3Y Avg
- 1.7%
- SBC, 3Y Avg
- $60.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $4.3B | $1.1B | 24.6% |
| FY2024 | $3.9B | $808.1M | 20.7% |
| FY2023 | $3.7B | $772.9M | 21.1% |
| FY2022 | $3.4B | $394.1M | 11.7% |
| FY2021 | $3.2B | $636.0M | 19.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 23, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back
Chipmakers Lead a Guidance Season Almost Free of Cuts